cartiva
-
Biologics
Wright Medical Group N.V. Highlights Recent Innovations and Clinical Data at the American Orthopaedic Foot & Ankle Society (AOFAS) 2019 Annual Meeting
AMSTERDAM, The Netherlands, Sept. 12, 2019 (GLOBE NEWSWIRE) — Wright Medical Group N.V. (NASDAQ: WMGI) announced it will highlight new…
Read More » -
Extremities
Cartiva Announces Presentation of Long-Term Clinical Data on Treating Big Toe Arthritis with Cartiva Synthetic Cartilage Implant
July 16, 2018 ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., (Company) a medical device company focused on the treatment of osteoarthritis of the…
Read More » -
Extremities
Cartiva, Inc., Announces Multiple Presentations at American Orthopaedic Foot and Ankle Society Annual Meeting 2017
July 10, 2017 ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc. (Company), a developer of innovative products for treating cartilage damage and osteoarthritis, announced…
Read More » -
Financial
Cartiva, Inc. Announces Financing Transactions
January 10, 2017 ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative products for the treatment of cartilage damage and osteoarthritis,…
Read More » -
Hospitals
MCRA Assists Cartiva, Inc. with Obtaining FDA PMA Approval for the Company’s Synthetic Cartilage Implant (SCI)
WASHINGTON, July 20, 2016 /PRNewswire-USNewswire/ — Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced today its role in the successful Premarket Approval (PMA) application…
Read More » -
Extremities
Cartiva, Inc. Announces First US Procedure for FDA Approved Cartiva Synthetic Cartilage Implant
July 12, 2016 ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc. announced today that the first commercial U.S. patient has received the Cartiva…
Read More » -
Hospitals
Cartiva, Inc. Announces FDA Premarket Approval for Cartiva Synthetic Cartilage Implant
July 05, 2016 ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative products for the treatment of cartilage damage and…
Read More » -
Hospitals
Cartiva Announces Publication of Results of Cartiva Synthetic Cartilage Implant Pivotal Study
(Alpharetta, GA, May 17, 2016) – Cartiva, Inc., (Company) a developer of innovative solutions for the treatment of cartilage damage,…
Read More » -
Extremities
FDA ORTHO PANEL TO VOTE ON CARTIVA SYNTHETIC CARTILAGE IMPLANT
Walter Eisner The FDA’s Orthopaedic and Rehabilitation Devices Panel will meet on April 20, 2016 to discuss, make recommendations, and…
Read More » -
Hospitals
Cartiva Announces GMP Certification by Brazil’s ANVISA
(Alpharetta, GA, October 26, 2015) – Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and…
Read More » -
Extremities
Cartiva Announces First Patient Enrolled in ProxiFuse Post Market Study
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and other musculoskeletal conditions,…
Read More » -
Extremities
Cartiva Announces Positive Final Data from its Cartiva SCI Pivotal Trial for Great Toe Arthritis
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and other musculoskeletal conditions,…
Read More » -
Financial
Cartiva, Inc. Closes $8.5 Million Financing
ALPHARETTA, Ga.–(BUSINESS WIRE)–Cartiva, Inc., (Company) a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced…
Read More » -
Financial
Cartiva Inc. Just Filed Form D Announcing $8.50 million Financing
By Octastaff Cartiva, Inc., Corporation just filed form D regarding $8.50 million financing. Cartiva, Inc. was able to sell $6.00…
Read More » -
Extremities
Cartiva Announces 510(k) Clearance for ProxiFuse Hammertoe Correction System
ALPHARETTA, GA. — Cartiva, Inc., (the “Company”) a developer of innovative solutions for the treatment of cartilage damage, osteoarthritis and…
Read More »